Biotech Stock 685% Draws Big Investment Amid FDA Filings
A biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
Choosing points over cash back can be beneficial in specific situations. Understand when to make that switch for better rewards.
27,195 articlesA biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
A regulatory proposal released March 19 could ease capital buffers for many U.S. banks, freeing up funds for lending,...
A crypto firm reaffirmed its ties to World Liberty, stating that the Trump family remains involved despite market vol...
Six ETFs now cover the entire grid-resilience thesis, from hardware and software to infrastructure and energy metals,...
As investors seek durable AI upside beyond chips, three ETFs focusing on the software layer beat peers and promise re...
Morgan Stanley and Galaxy Digital roll out a pilot allowing eligible clients to lend crypto in return for in-kind cry...
Off-camera chatter from the G7 summit captured personal habits and light banter, including meloni quit smoking; notor...
Meta is pursuing a new play-money prediction market, Arena, designed to test engagement and data signals while naviga...
A CFO selling NuScale stock can spark questions about the company’s outlook. This guide breaks down what the move mig...
Netflix has opted not to top Paramount's offer, prompting Warner Bros. Discovery to align with Paramount. The move co...
As geopolitical tensions rise, investors reassess defense exposure. This report examines the weapons that changed war...
Political headlines move markets—and your finances. This guide shows how statements like donald trump publicly blames...